Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts relation to eddy blood flow

Shu Qian Liu*

*Corresponding author for this work

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Eddy flow has been shown to promote focal smooth muscle cell (SMC) proliferation and neointimal formation in experimental vein grafts. This study focuses on whether the angiotensin II type 1 (AT1) receptor mediates these events. Experimental vein grafts with and without eddy flow were created in the rat. Losartan was used to assess the influence of the AT1 receptor on SMC proliferation. In vein grafts with eddy flow, apparent focal expression of AT, mRNA and protein was found in the leading region of the proximal focal neointima, where eddy flow occurred, but not in the trailing region, where eddy flow diminished, at days 5,10,20, and 30. The rate of SMC proliferation in the leading region (10.9±1.4%, 19.5±2.2%, 12.2±2.0%, and 6.9± 1.3% at these times, respectively) was significantly higher than that in the trailing region (9.5±1.8%, 15.3±2.0%, 8.2±1.9%, and 3.2±0.7%) in these vein grafts. When eddy flow was prevented in engineered vein grafts, no apparent location difference was found in the distribution of AT, receptor mRNA and protein in the neointima, and the rate of SMC proliferation (5.3±1.0%, 5.8±0.9%, 3.4±1.0%, and 3.7±0.9% at days 5, 10, 20, and 30, respectively) was reduced significantly. In vein grafts with losartan, the rate of SMC proliferation in the leading region of the neointima (9.4±1.8%, 10.1±1.3%, 8.3±0.9%, and 4.2±0.5% at days 5, 10, 20, and 30, respectively) was significantly lower than that in vein grafts without losartan. These results suggested that eddy flow unregulated the AT1 receptor, which in turn mediated focal SMC proliferation in the neointima of experimental vein grafts.

Original languageEnglish (US)
Pages (from-to)2630-2639
Number of pages10
JournalArteriosclerosis, thrombosis, and vascular biology
Volume19
Issue number11
DOIs
StatePublished - Jan 1 1999

Fingerprint

Neointima
Angiotensin Type 1 Receptor
Smooth Muscle Myocytes
Veins
Cell Proliferation
Transplants
Losartan
Messenger RNA
Proteins

Keywords

  • Fluid shear stress
  • Intimal hyperplasia
  • Tensile stress
  • Vascular tissue engineering

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{8731b959a83e4702be6bcc1824ce1329,
title = "Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts relation to eddy blood flow",
abstract = "Eddy flow has been shown to promote focal smooth muscle cell (SMC) proliferation and neointimal formation in experimental vein grafts. This study focuses on whether the angiotensin II type 1 (AT1) receptor mediates these events. Experimental vein grafts with and without eddy flow were created in the rat. Losartan was used to assess the influence of the AT1 receptor on SMC proliferation. In vein grafts with eddy flow, apparent focal expression of AT, mRNA and protein was found in the leading region of the proximal focal neointima, where eddy flow occurred, but not in the trailing region, where eddy flow diminished, at days 5,10,20, and 30. The rate of SMC proliferation in the leading region (10.9±1.4{\%}, 19.5±2.2{\%}, 12.2±2.0{\%}, and 6.9± 1.3{\%} at these times, respectively) was significantly higher than that in the trailing region (9.5±1.8{\%}, 15.3±2.0{\%}, 8.2±1.9{\%}, and 3.2±0.7{\%}) in these vein grafts. When eddy flow was prevented in engineered vein grafts, no apparent location difference was found in the distribution of AT, receptor mRNA and protein in the neointima, and the rate of SMC proliferation (5.3±1.0{\%}, 5.8±0.9{\%}, 3.4±1.0{\%}, and 3.7±0.9{\%} at days 5, 10, 20, and 30, respectively) was reduced significantly. In vein grafts with losartan, the rate of SMC proliferation in the leading region of the neointima (9.4±1.8{\%}, 10.1±1.3{\%}, 8.3±0.9{\%}, and 4.2±0.5{\%} at days 5, 10, 20, and 30, respectively) was significantly lower than that in vein grafts without losartan. These results suggested that eddy flow unregulated the AT1 receptor, which in turn mediated focal SMC proliferation in the neointima of experimental vein grafts.",
keywords = "Fluid shear stress, Intimal hyperplasia, Tensile stress, Vascular tissue engineering",
author = "Liu, {Shu Qian}",
year = "1999",
month = "1",
day = "1",
doi = "10.1161/01.ATV.19.11.2630",
language = "English (US)",
volume = "19",
pages = "2630--2639",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts relation to eddy blood flow

AU - Liu, Shu Qian

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Eddy flow has been shown to promote focal smooth muscle cell (SMC) proliferation and neointimal formation in experimental vein grafts. This study focuses on whether the angiotensin II type 1 (AT1) receptor mediates these events. Experimental vein grafts with and without eddy flow were created in the rat. Losartan was used to assess the influence of the AT1 receptor on SMC proliferation. In vein grafts with eddy flow, apparent focal expression of AT, mRNA and protein was found in the leading region of the proximal focal neointima, where eddy flow occurred, but not in the trailing region, where eddy flow diminished, at days 5,10,20, and 30. The rate of SMC proliferation in the leading region (10.9±1.4%, 19.5±2.2%, 12.2±2.0%, and 6.9± 1.3% at these times, respectively) was significantly higher than that in the trailing region (9.5±1.8%, 15.3±2.0%, 8.2±1.9%, and 3.2±0.7%) in these vein grafts. When eddy flow was prevented in engineered vein grafts, no apparent location difference was found in the distribution of AT, receptor mRNA and protein in the neointima, and the rate of SMC proliferation (5.3±1.0%, 5.8±0.9%, 3.4±1.0%, and 3.7±0.9% at days 5, 10, 20, and 30, respectively) was reduced significantly. In vein grafts with losartan, the rate of SMC proliferation in the leading region of the neointima (9.4±1.8%, 10.1±1.3%, 8.3±0.9%, and 4.2±0.5% at days 5, 10, 20, and 30, respectively) was significantly lower than that in vein grafts without losartan. These results suggested that eddy flow unregulated the AT1 receptor, which in turn mediated focal SMC proliferation in the neointima of experimental vein grafts.

AB - Eddy flow has been shown to promote focal smooth muscle cell (SMC) proliferation and neointimal formation in experimental vein grafts. This study focuses on whether the angiotensin II type 1 (AT1) receptor mediates these events. Experimental vein grafts with and without eddy flow were created in the rat. Losartan was used to assess the influence of the AT1 receptor on SMC proliferation. In vein grafts with eddy flow, apparent focal expression of AT, mRNA and protein was found in the leading region of the proximal focal neointima, where eddy flow occurred, but not in the trailing region, where eddy flow diminished, at days 5,10,20, and 30. The rate of SMC proliferation in the leading region (10.9±1.4%, 19.5±2.2%, 12.2±2.0%, and 6.9± 1.3% at these times, respectively) was significantly higher than that in the trailing region (9.5±1.8%, 15.3±2.0%, 8.2±1.9%, and 3.2±0.7%) in these vein grafts. When eddy flow was prevented in engineered vein grafts, no apparent location difference was found in the distribution of AT, receptor mRNA and protein in the neointima, and the rate of SMC proliferation (5.3±1.0%, 5.8±0.9%, 3.4±1.0%, and 3.7±0.9% at days 5, 10, 20, and 30, respectively) was reduced significantly. In vein grafts with losartan, the rate of SMC proliferation in the leading region of the neointima (9.4±1.8%, 10.1±1.3%, 8.3±0.9%, and 4.2±0.5% at days 5, 10, 20, and 30, respectively) was significantly lower than that in vein grafts without losartan. These results suggested that eddy flow unregulated the AT1 receptor, which in turn mediated focal SMC proliferation in the neointima of experimental vein grafts.

KW - Fluid shear stress

KW - Intimal hyperplasia

KW - Tensile stress

KW - Vascular tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=0032724237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032724237&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.19.11.2630

DO - 10.1161/01.ATV.19.11.2630

M3 - Article

C2 - 10559005

AN - SCOPUS:0032724237

VL - 19

SP - 2630

EP - 2639

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -